First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression
一线治疗方案:替雷利珠单抗联合贝伐珠单抗和CAPOX方案,用于治疗程序性死亡配体1(PD-L1)表达低的转移性胃食管腺癌
期刊:Cancer Communications
影响因子:24.9
doi:10.34133/cancomm.0024
Jia, Ru; Wang, Yan-Rong; Liu, Fang-Fang; Ma, Yue; Si, Hai-Yan; Han, Lu; Gou, Miao-Miao; Tan, Zhao-Li; Zhang, Nan; Deng, Guo-Chao; Fan, Meng-Jiao; Shi, Yue; Zhang, Yao-Yue; Jia, Yu-Shan; Xu, Jun-Nan; Su, Xiao-Xing; Han, Quan-Li; Wang, Zhi-Kuan; Dai, Guang-Hai